/
/
/

Orchid Pharma Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
-6%14%18%13%
---1%
-18%19%26%
-37%1%9%8%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
LUPIN
MANKIND
DRREDDY
AUROPHARMA
ORCHPHARMA
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,901.1₹456833 Cr37.7712.0762.82₹11479 Cr
9,180₹245426 Cr83.9134.04128.41₹2568 Cr
4,862₹187320 Cr85.8916.7297.06₹2163 Cr
1,131.5₹113217 Cr25.099.4262.53₹5040 Cr
1,379.7₹112212 Cr33.299.7757.87₹3879 Cr
1,853.2₹101155 Cr92.526.829.25₹889 Cr
2,122.9₹97626 Cr17.6630.95154.36₹5333 Cr
2,335.2₹96859 Cr47.4213.7571.08₹1913 Cr
1,161.4₹96406 Cr29.925.3263.99₹4196 Cr
1,655.8₹93614 Cr25.2217.9596.84₹3505 Cr
944.25₹5597 Cr645.910.547.75₹21 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Dec 2011Dec 2010Dec 2009Dec 2008Jun 2008Jun 2007Jun 2006
₹304 Cr₹238 Cr₹207 Cr₹194 Cr₹263 Cr₹237 Cr₹217 Cr₹223 Cr₹244 Cr₹217 Cr₹221 Cr₹199 Cr₹183 Cr₹210 Cr₹160 Cr₹165 Cr₹131 Cr₹178 Cr₹161 Cr₹128 Cr₹92 Cr₹120 Cr₹103 Cr₹109 Cr₹119 Cr₹112 Cr₹129 Cr₹132 Cr₹135 Cr₹497 Cr₹479 Cr₹360 Cr₹336 Cr₹310 Cr₹252 Cr₹213 Cr
₹2 Cr₹7 Cr₹6 Cr₹11 Cr₹12 Cr₹4 Cr₹8 Cr₹8 Cr₹8 Cr₹13 Cr₹8 Cr₹8 Cr₹2 Cr₹2 Cr₹9 Cr₹6 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹11 Cr₹2 Cr₹93 L₹1 Cr₹6 Cr₹7 Cr₹7 Cr₹5 Cr₹0₹3 L₹0₹1 L₹18 Cr₹53 Cr₹75 L
₹306 Cr₹245 Cr₹213 Cr₹204 Cr₹275 Cr₹241 Cr₹226 Cr₹230 Cr₹252 Cr₹230 Cr₹228 Cr₹207 Cr₹185 Cr₹212 Cr₹169 Cr₹171 Cr₹134 Cr₹180 Cr₹164 Cr₹130 Cr₹95 Cr₹131 Cr₹105 Cr₹109 Cr₹120 Cr₹117 Cr₹136 Cr₹138 Cr₹141 Cr₹497 Cr₹479 Cr₹360 Cr₹336 Cr₹328 Cr₹305 Cr₹213 Cr
₹301 Cr₹220 Cr₹215 Cr₹204 Cr₹279 Cr₹218 Cr₹200 Cr₹201 Cr₹220 Cr₹197 Cr₹194 Cr₹183 Cr₹168 Cr₹177 Cr₹154 Cr₹165 Cr₹140 Cr₹179 Cr₹168 Cr₹137 Cr₹113 Cr₹122 Cr₹137 Cr₹121 Cr₹130 Cr₹155 Cr₹161 Cr₹164 Cr₹179 Cr₹406 Cr₹380 Cr₹328 Cr₹268 Cr₹273 Cr₹215 Cr₹177 Cr
₹16 Cr₹34 Cr₹7 Cr₹9 Cr₹6 Cr₹32 Cr₹35 Cr₹38 Cr₹40 Cr₹42 Cr₹43 Cr₹32 Cr₹24 Cr₹41 Cr₹23 Cr₹24 Cr₹15 Cr₹28 Cr₹16 Cr₹13 Cr₹3 Cr₹29 Cr-₹3 Cr₹19 Cr₹21 Cr-₹7 Cr₹7 Cr₹6 Cr-₹7 Cr₹129 Cr₹131 Cr₹72 Cr₹101 Cr₹87 Cr₹114 Cr₹56 Cr
₹2 Cr₹3 Cr₹3 Cr₹4 Cr₹2 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹4 Cr₹4 Cr₹6 Cr₹7 Cr₹8 Cr₹9 Cr₹8 Cr₹4 Cr₹7 Cr₹10 Cr₹11 Cr₹12 Cr₹13 Cr₹13 Cr₹14 Cr₹78 L₹3 Cr₹9 L₹0₹50 Cr₹27 Cr₹54 Cr₹38 Cr₹30 Cr₹17 Cr₹22 Cr
₹3 Cr₹23 Cr-₹12 Cr-₹3 Cr-₹7 Cr₹19 Cr₹22 Cr₹26 Cr₹28 Cr₹30 Cr₹30 Cr₹20 Cr₹11 Cr₹66 Cr₹7 Cr-₹3 Cr-₹14 Cr-₹4 Cr-₹11 Cr-₹17 Cr-₹28 Cr-₹3 Cr-₹45 Cr-₹24 Cr-₹23 Cr-₹39 Cr-₹28 Cr-₹26 Cr-₹38 Cr-₹8 Cr₹76 Cr-₹17 Cr-₹1 Cr-₹34 Cr₹73 Cr₹14 Cr
₹3 Cr₹23 Cr-₹12 Cr-₹3 Cr-₹7 Cr₹19 Cr₹22 Cr₹26 Cr₹28 Cr₹34 Cr₹30 Cr₹20 Cr₹11 Cr₹59 Cr₹7 Cr-₹3 Cr-₹14 Cr-₹5 Cr-₹14 Cr₹49 Cr-₹31 Cr-₹25 Cr-₹45 Cr-₹24 Cr-₹23 Cr-₹39 Cr-₹28 Cr-₹26 Cr-₹38 Cr-₹11 Cr₹57 Cr-₹19 Cr-₹5 Cr-₹34 Cr₹49 Cr₹11 Cr

Balance Sheet

Consolidated
Standalone
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Trade Payables
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Sep 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008Mar 2007Mar 2006
₹51 Cr₹51 Cr₹41 Cr₹41 Cr₹41 Cr₹41 Cr₹89 Cr₹89 Cr₹89 Cr₹89 Cr₹85 Cr₹70 Cr₹70 Cr₹70 Cr₹70 Cr₹70 Cr₹66 Cr₹66 Cr₹65 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹96,000₹0
₹1217 Cr₹1119 Cr₹648 Cr₹607 Cr₹612 Cr₹725 Cr-₹793 Cr-₹881 Cr-₹477 Cr-₹40 Cr₹244 Cr₹310 Cr₹1062 Cr₹999 Cr₹867 Cr₹563 Cr₹599 Cr₹419 Cr₹711 Cr
₹1217 Cr₹1119 Cr₹648 Cr₹607 Cr₹612 Cr₹725 Cr-₹793 Cr-₹881 Cr-₹477 Cr-₹40 Cr₹244 Cr₹310 Cr₹1062 Cr₹999 Cr₹867 Cr₹563 Cr₹599 Cr₹419 Cr₹711 Cr
₹1267 Cr₹1169 Cr₹689 Cr₹647 Cr₹653 Cr₹766 Cr-₹704 Cr-₹792 Cr-₹388 Cr₹49 Cr₹329 Cr₹380 Cr₹1132 Cr₹1069 Cr₹938 Cr₹634 Cr₹665 Cr₹485 Cr₹776 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹62 L₹3 Cr₹2 Cr₹0₹0₹0₹0₹0
₹0₹22 L₹40 Cr₹111 Cr₹342 Cr₹430 Cr₹1425 Cr₹1894 Cr₹2157 Cr₹2378 Cr₹2494 Cr₹902 Cr₹1074 Cr₹604 Cr₹1036 Cr₹1714 Cr₹980 Cr₹707 Cr₹843 Cr
₹132 Cr₹120 Cr₹109 Cr₹97 Cr₹86 Cr₹74 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹625 Cr₹902 Cr₹991 Cr₹942 Cr₹202 Cr
-₹10 L₹0₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹46 Cr₹94 Cr₹111 Cr₹157 Cr₹170 Cr₹194 Cr₹203 Cr₹128 Cr₹115 Cr₹92 Cr₹80 Cr
₹4 L₹37 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹42 Cr₹0₹0₹0₹0₹0
₹3 Cr₹4 Cr₹13 Cr₹11 Cr₹12 Cr₹12 Cr₹8 Cr₹7 Cr₹2 Cr₹4 Cr₹4 Cr₹5 Cr₹8 Cr₹10 Cr₹0₹0₹0₹0₹0
₹135 Cr₹124 Cr₹165 Cr₹222 Cr₹442 Cr₹519 Cr₹1436 Cr₹1905 Cr₹2205 Cr₹2475 Cr₹2609 Cr₹1064 Cr₹1252 Cr₹850 Cr₹1864 Cr₹2744 Cr₹2085 Cr₹1741 Cr₹1125 Cr
₹222 Cr₹230 Cr₹174 Cr₹168 Cr₹110 Cr₹102 Cr₹302 Cr₹359 Cr₹425 Cr₹374 Cr₹311 Cr₹597 Cr₹447 Cr₹335 Cr₹318 Cr₹390 Cr₹296 Cr₹235 Cr₹216 Cr
₹19 Cr₹14 Cr₹53 Cr₹47 Cr₹26 Cr₹70 Cr₹1344 Cr₹958 Cr₹476 Cr₹285 Cr₹113 Cr₹1053 Cr₹407 Cr₹1005 Cr₹294 Cr₹369 Cr₹359 Cr₹389 Cr₹23 Cr
₹43 Cr₹14 Cr₹141 Cr₹23 Cr₹3 Cr₹0₹695 Cr₹694 Cr₹600 Cr₹634 Cr₹647 Cr₹1525 Cr₹647 Cr₹490 Cr₹0₹0₹0₹0₹0
₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹4 Cr₹3 Cr₹4 Cr₹1 Cr₹40 Cr₹44 Cr₹52 Cr₹31 Cr₹50 Cr₹159 Cr₹360 Cr₹97 Cr₹78 Cr₹42 Cr₹30 Cr
₹286 Cr₹260 Cr₹372 Cr₹241 Cr₹142 Cr₹175 Cr₹2346 Cr₹2013 Cr₹1541 Cr₹1338 Cr₹1123 Cr₹3206 Cr₹1551 Cr₹1989 Cr₹972 Cr₹856 Cr₹734 Cr₹665 Cr₹268 Cr
₹1688 Cr₹1554 Cr₹1225 Cr₹1111 Cr₹1237 Cr₹1460 Cr₹3077 Cr₹3125 Cr₹3358 Cr₹3862 Cr₹4061 Cr₹4651 Cr₹3938 Cr₹3910 Cr₹3774 Cr₹4234 Cr₹3484 Cr₹2891 Cr₹2169 Cr
₹14 Cr₹57 Cr₹42 Cr₹43 Cr₹45 Cr₹0₹143 Cr₹162 Cr₹141 Cr₹71 Cr₹107 Cr₹168 Cr₹531 Cr₹322 Cr₹405 Cr₹365 Cr₹385 Cr₹269 Cr₹303 Cr
₹174 Cr₹134 Cr₹331 Cr₹268 Cr₹453 Cr₹566 Cr₹3230 Cr₹3202 Cr₹3106 Cr₹3215 Cr₹3211 Cr₹3204 Cr₹2005 Cr₹2079 Cr₹1661 Cr₹2616 Cr₹1971 Cr₹1649 Cr₹1045 Cr
₹1348 Cr₹1301 Cr₹1221 Cr₹1176 Cr₹1176 Cr₹1247 Cr₹1520 Cr₹1519 Cr₹3006 Cr₹3006 Cr₹3002 Cr₹3772 Cr₹3090 Cr₹2614 Cr₹2345 Cr₹2696 Cr₹2098 Cr₹1563 Cr₹1364 Cr
₹715 Cr₹681 Cr₹647 Cr₹593 Cr₹506 Cr₹389 Cr₹263 Cr₹133 Cr₹1509 Cr₹1369 Cr₹1207 Cr₹1189 Cr₹1016 Cr₹872 Cr₹741 Cr₹688 Cr₹558 Cr₹458 Cr₹374 Cr
₹633 Cr₹620 Cr₹573 Cr₹584 Cr₹670 Cr₹858 Cr₹1256 Cr₹1386 Cr₹1497 Cr₹1637 Cr₹1795 Cr₹2584 Cr₹2074 Cr₹1742 Cr₹1603 Cr₹2008 Cr₹1540 Cr₹1105 Cr₹990 Cr
₹64 Cr₹16 Cr₹46 Cr₹10 Cr₹7 Cr₹15 Cr₹264 Cr₹257 Cr₹274 Cr₹265 Cr₹267 Cr₹332 Cr₹329 Cr₹322 Cr₹469 Cr₹547 Cr₹620 Cr₹553 Cr₹270 Cr
₹50 Cr₹46 Cr₹44 Cr₹45 Cr₹40 L₹34 L₹47 L₹1 Cr₹96 L₹81 L₹81 L₹95 L₹81 L₹81 L₹0₹0₹0₹0₹0
₹50 Cr₹46 Cr₹44 Cr₹45 Cr₹40 L₹34 L₹47 L₹1 Cr₹96 L₹81 L₹81 L₹95 L₹81 L₹81 L₹0₹0₹0₹0₹0
₹117 Cr₹66 Cr₹60 Cr₹74 Cr₹9 Cr₹7 Cr₹765 Cr₹778 Cr₹687 Cr₹681 Cr₹683 Cr₹577 Cr₹221 Cr₹296 Cr₹0₹0₹0₹0₹0
₹2 L₹2 L₹0₹74,000₹1 L₹0₹10 Cr₹10 Cr₹6 Cr₹12 Cr₹23 Cr₹28 Cr₹37 Cr₹13 Cr₹0₹0₹0₹0₹0
₹880 Cr₹763 Cr₹724 Cr₹713 Cr₹687 Cr₹891 Cr₹2310 Cr₹2446 Cr₹2479 Cr₹2611 Cr₹2783 Cr₹3550 Cr₹2685 Cr₹2384 Cr₹2072 Cr₹2554 Cr₹2160 Cr₹1658 Cr₹1261 Cr
₹0₹0₹0₹0₹15 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹81 L₹81 L₹81 L₹8 L₹8 L
₹326 Cr₹264 Cr₹229 Cr₹173 Cr₹153 Cr₹142 Cr₹170 Cr₹194 Cr₹211 Cr₹242 Cr₹252 Cr₹506 Cr₹669 Cr₹618 Cr₹423 Cr₹768 Cr₹649 Cr₹612 Cr₹448 Cr
₹242 Cr₹196 Cr₹215 Cr₹171 Cr₹136 Cr₹68 Cr₹120 Cr₹120 Cr₹203 Cr₹310 Cr₹257 Cr₹179 Cr₹113 Cr₹513 Cr₹737 Cr₹673 Cr₹538 Cr₹383 Cr₹349 Cr
₹180 Cr₹267 Cr₹31 Cr₹8 Cr₹20 Cr₹174 Cr₹326 Cr₹306 Cr₹257 Cr₹315 Cr₹391 Cr₹23 Cr₹177 Cr₹201 Cr₹335 Cr₹53 Cr₹31 Cr₹119 Cr₹16 Cr
₹6 Cr₹7 Cr₹4 Cr₹13 Cr₹10 Cr₹22 Cr₹12 Cr₹20 Cr₹9 Cr₹117 Cr₹80 L₹14 Cr₹16 Cr₹9 Cr₹4 Cr₹5 Cr₹4 Cr₹3 Cr₹2 Cr
₹54 Cr₹57 Cr₹23 Cr₹20 Cr₹96 Cr₹164 Cr₹140 Cr₹40 Cr₹198 Cr₹268 Cr₹378 Cr₹378 Cr₹278 Cr₹185 Cr₹201 Cr₹97 Cr₹102 Cr₹116 Cr₹93 Cr
₹807 Cr₹791 Cr₹501 Cr₹384 Cr₹429 Cr₹569 Cr₹767 Cr₹679 Cr₹879 Cr₹1251 Cr₹1278 Cr₹1101 Cr₹1253 Cr₹1526 Cr₹1701 Cr₹1596 Cr₹1324 Cr₹1233 Cr₹908 Cr
₹522 Cr₹531 Cr₹129 Cr₹144 Cr₹287 Cr₹394 Cr-₹1578 Cr-₹1334 Cr-₹662 Cr-₹86 Cr₹155 Cr-₹2105 Cr-₹298 Cr-₹463 Cr₹729 Cr₹740 Cr₹590 Cr₹568 Cr₹640 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹84 Cr₹0₹0₹0
₹1688 Cr₹1554 Cr₹1225 Cr₹1111 Cr₹1237 Cr₹1460 Cr₹3077 Cr₹3125 Cr₹3358 Cr₹3862 Cr₹4061 Cr₹4651 Cr₹3938 Cr₹3910 Cr₹3774 Cr₹4234 Cr₹3484 Cr₹2891 Cr₹2169 Cr
₹250₹231₹169₹159₹160₹188-₹79-₹89-₹44₹6₹39₹54₹161₹152₹133₹78₹101₹74₹120
₹250₹231₹169₹159₹160₹188-₹79-₹89-₹44₹6₹39₹54₹161₹152₹133₹78₹101₹74₹120

Cash Flow

Consolidated
Standalone
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Sep 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008Mar 2007
₹99 Cr₹89 Cr₹46 Cr-₹2 Cr-₹117 Cr-₹131 Cr₹69 Cr-₹399 Cr-₹452 Cr-₹296 Cr-₹243 Cr-₹573 Cr₹75 Cr₹172 Cr₹470 Cr-₹34 Cr₹229 Cr₹93 Cr
₹29 Cr₹44 Cr₹51 Cr₹37 Cr₹172 Cr₹140 Cr₹57 Cr₹453 Cr₹582 Cr₹490 Cr₹1006 Cr₹661 Cr₹334 Cr₹215 Cr-₹557 Cr₹200 Cr₹132 Cr₹189 Cr
-₹109 Cr-₹8 Cr-₹79 Cr₹60 Cr-₹37 Cr₹62 Cr-₹110 Cr-₹38 Cr₹187 Cr₹18 Cr-₹669 Cr₹79 Cr₹357 Cr₹7 Cr₹119 Cr-₹117 Cr-₹118 Cr-₹184 Cr
₹20 Cr₹125 Cr₹19 Cr₹94 Cr₹19 Cr₹70 Cr₹16 Cr₹16 Cr₹317 Cr₹212 Cr₹94 Cr₹168 Cr₹766 Cr₹393 Cr₹32 Cr₹49 Cr₹243 Cr₹97 Cr
₹19 Cr₹126 Cr₹18 Cr₹92 Cr₹24 Cr₹81 Cr₹12 Cr₹9 Cr₹317 Cr₹212 Cr-₹369 Cr₹168 Cr₹737 Cr₹332 Cr-₹34 Cr₹46 Cr₹210 Cr₹96 Cr
-₹27 Cr-₹312 Cr-₹31 Cr₹113 Cr₹67 Cr₹167 Cr₹45 Cr-₹28 Cr-₹9 Cr-₹1 Cr₹1334 Cr-₹986 Cr-₹293 Cr-₹367 Cr₹1413 Cr-₹477 Cr-₹545 Cr-₹477 Cr
₹25 Cr₹167 Cr₹31 Cr-₹217 Cr-₹165 Cr-₹250 Cr-₹30 L₹33 Cr-₹366 Cr-₹286 Cr-₹597 Cr₹664 Cr-₹480 Cr-₹78 Cr-₹1077 Cr₹431 Cr₹247 Cr₹485 Cr
₹18 Cr-₹19 Cr₹18 Cr-₹11 Cr-₹74 Cr-₹2 Cr₹57 Cr₹15 Cr-₹58 Cr-₹76 Cr₹367 Cr-₹153 Cr-₹36 Cr-₹113 Cr₹302 Cr₹2 L-₹88 Cr₹104 Cr
₹4 Cr₹23 Cr₹4 Cr₹16 Cr₹90 Cr₹92 Cr₹35 Cr₹21 Cr₹315 Cr₹391 Cr₹23 Cr₹177 Cr₹213 Cr₹326 Cr₹24 Cr₹24 Cr₹112 Cr₹8 Cr
₹21 Cr₹4 Cr₹23 Cr₹4 Cr₹16 Cr₹90 Cr₹92 Cr₹35 Cr₹257 Cr₹315 Cr₹391 Cr₹23 Cr₹177 Cr₹213 Cr₹326 Cr₹24 Cr₹24 Cr₹112 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)937.00
Volume (₹)23,096.00
High (₹)963.00
Upper Circuit1,121.55
Low (₹)934.70
Lower Circuit747.75
Prev Close934.65
52W High (₹)1,133.00
Price944.25
52W Low (₹)480.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)5597.47 Cr
Div. Yield (%)0.00
PE Ratio645.91
Debt to Equity0.14
Price to Book3.11
Book Value249.86
EPS (TTM)1.45
Face Value10.00
ROE (%)7.86

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
ORCHPHARMANSE
LTP
1W Low
1W High
Market cap (₹)
1901.1-18.9 (-0.98%)
1900.10
1984.80
4,56,833Cr
9180-59 (-0.64%)
9087
9467
2,45,426Cr
4862-188 (-3.72%)
4857
5066
1,87,320Cr
1131.5-59.5 (-5.00%)
1125.10
1187
1,13,217Cr
1379.7-43.8 (-3.08%)
1376.70
1426.10
1,12,212Cr
1853.2-85.3 (-4.40%)
1811.70
1949
1,01,155Cr
2122.9-48.6 (-2.24%)
2118.10
2192
97,626Cr
2335.2-47.7 (-2.00%)
2335
2419.20
96,859Cr
1161.4-16.6 (-1.41%)
1154.40
1179.90
96,406Cr
1655.8+10.5 (0.64%)
1622.60
1717
93,614Cr
944.25-31.35 (-3.21%)
931.10
1000
5,597Cr

Orchid Pharma Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹15.83Cr; with other income of ₹1.83Cr, profit before interest and tax came to ₹4.88Cr. Interest expense was ₹2.23Cr; PBT before exceptional items stood at ₹2.65Cr. Cost mix (full year): raw materials ₹588.07Cr; employee cost ₹86.36Cr; depreciation ₹10.95Cr; other expenses ₹290.17Cr. Basis: consolidated annual results.

Orchid Pharma Ltd Quaterly Results Key Takeaways

Orchid Pharma Ltd reported ₹304.17Cr total income from operations in Jun 2026, softer than ₹237.61Cr in Mar 2026 but higher than ₹263.19Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹15.83Cr; with other income of ₹1.83Cr, profit before interest and tax came to ₹4.88Cr. Interest expense was ₹2.23Cr, taking profit before tax to ₹2.65Cr. After tax of ₹7.2Lakh, profit after tax stood at ₹2.58Cr (vs ₹22.78Cr in Mar 2026 and ₹-₹6.89Cr in Jun 2025).